NEOGEN

Neogen Chemicals share price & results

Neogen Chemicals Limited· Chemicals· Commodities

Results to
Sept 2026
Latest analysed call
Q2 FY27
Ownership as of
Sept 2026

Manufactures Bromine and Lithium-based specialty chemicals; expanding into EV battery materials.

Company research is public. Sign in to keep your own companies, notes and cases.

Inve AI Signals on NEOGEN
Direct bridge to live research & tools watching Neogen Chemicals Limited
Guidance Hit Rate
33 targets · 20% hit rate 2 achieved · 23 active →
Segment Shift
Sector & Mix Compare sector growth & peers →
Reverse DCF
Implied Growth Test priced-in growth in DCF tool →
Concall & Tone
Q2 FY27 analysed Read claims, qualifiers & Q&A →

Price & Snapshot

₹2,665.2 +1.40% · +₹36.7

Last close 9 Nov 2026 · NSE · INR · Source: Inve

Performance +83.5% 1Y

₹1.0k₹1.5k₹2.0k₹2.5kNov 25Dec 25Feb 26Mar 26May 26Jun 26Aug 26Sept 26Nov 26Q2 FY26 — 10 Nov 2025Q3 FY26 — 12 Feb 2026Q4 FY26 — 18 May 2026Q1 FY27 — 27 Jul 2026Q2 FY27 — 2 Nov 2026

1Y: ₹1,452.3 on 7 Nov 2025 → ₹2,665.2. High ₹2,687.9 (14 Oct 2026), low ₹979.8 (9 Dec 2025).

Previous close
₹2,628.5
Market cap
₹7.9k Cr
52-week range
₹979.8 – ₹2,687.9
One year
+103.68%
Price to earnings (TTM to Sept 2026)
195.37×
Return on equity (TTM to Sept 2026)
2.56%

Reported

Key financial metrics & valuation ratios

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue39.0 ₹ crore+457.1% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin19.0 %+2.0 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit21.0 ₹ crore+133.3% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equity2.56 %−2.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026
Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-75.06 %−59.4 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026
(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)26.66 %−1.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026
Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Guidance

What management said, and what became of it

2 of 10 judged targets kept · 23 open · verdicts reflect calls analysed to Q2 FY27.

Neogen Chemicals Limited management guidance track record on Inve: 33 targets tracked across analysed earnings calls (2 achieved, 8 missed, 23 open).

Watch execution in Growth & Demand (1 achieved · 2 delayed/missed).

TargetOriginal wordingSaidLatest callVerdict
Growth FY26 Battery Chemicals Revenue
Rs. 400 crore to Rs. 500 crore
Call transcript, Q2 FY25 · 13 Nov 2024
Q2 FY25
Q2 FY27:Historical target already met on a diluted basis.
Call transcript, Q2 FY27 · 2 Nov 2026
Achieved*
Growth FY25 Battery Chemicals Revenue
Rs. 75 crore to Rs. 100 crore
Call transcript, Q2 FY25 · 13 Nov 2024
Q2 FY25
Q2 FY27:Historical target already missed.
Call transcript, Q2 FY27 · 2 Nov 2026
Missed
Growth FY27 Battery Chemicals Revenue
above Rs. 1,000 crore
Call transcript, Q2 FY25 · 13 Nov 2024
Q2 FY25
Q2 FY27:Management slightly trimmed FY27 battery chemicals guidance to INR 250-300 crore (from INR 300 crore), citing electrolyte volume ramp-up timing and approval schedules at Pakhajan. Q2 battery revenue reached INR 37 crore.
Call transcript, Q2 FY27 · 2 Nov 2026
Revised Down

Source: Inve Guidance Tracker for Neogen Chemicals Limited · to Q2 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

8 of Neogen Chemicals Limited's 33 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 30 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Supply chain

Cross-company call evidence

Named counterparties and similar headwinds disclosed on earnings calls.

Counterparties named by Neogen Chemicals Limited

  • Neogen Chemicals Limited → divests to → Neogen Morita New Materials Limited (NML) - Consolidation of lithium-ion electrolyte salt undertaking.

    Q2 FY27 · Announced · Neutral · Counterparty named; listed-company identity not verified.

    1. Proposed
    2. Announced
    3. Active
    4. Completed / ended

    Consolidate the lithium-ion electrolyte salt (including LiPF6) undertaking under step-down subsidiary Neogen Morita New Materials Limited

    Disclosed value: INR 245 crores

    “Further, Neogen Ionics Limited has executed a business transfer agreement to consolidate the lithium-ion electrolyte salt (including LiPF6), undertaking under our step-down subsidiary Neogen Morita New Materials Limited (NML) for a cash consideration of INR 245 crore on a going concern basis, which also includes INR 77 crore already infused by Morita through preference allotment recently.”
    Evidence drawer

    Evidence type: Transcript excerpt

    “Further, Neogen Ionics Limited has executed a business transfer agreement to consolidate the lithium-ion electrolyte salt (including LiPF6), undertaking under our step-down subsidiary Neogen Morita New Materials Limited (NML) for a cash consideration of INR 245 crore on a going concern basis, which also includes INR 77 crore already infused by Morita through preference allotment recently.”

    Source company: Neogen Chemicals Limited · Counterparty: Neogen Morita New Materials Limited (NML) - Consolidation of lithium-ion electrolyte salt undertaking · Call date: 2026-11-02 · Period: Q2 FY27 · Review status: Structured call extraction

  • Neogen Chemicals Limited → partners with → Morita Joint Venture.

    Q4 FY26 · Announced · Positive · Counterparty named; listed-company identity not verified.

    1. Proposed
    2. Announced
    3. Active
    4. Completed / ended

    Building India's first non-FEOC compliant electrolyte salt manufacturing platform backed by proven Japanese technology

    Disclosed value: USD 20 million

    “Our strategic partnership with Japan's Morita continues to progress well, and their planned equity contribution of $20 million towards the joint venture is expected during the H1FY27.”

    Exact commercial direction is not specified; disclosed as a partnership or collaboration.

    Evidence drawer

    Evidence type: Transcript excerpt

    “Our strategic partnership with Japan's Morita continues to progress well, and their planned equity contribution of $20 million towards the joint venture is expected during the H1FY27.”

    Source company: Neogen Chemicals Limited · Counterparty: Morita Joint Venture · Call date: 2026-05-18 · Period: Q4 FY26 · Review status: Structured call extraction

  • Neogen Chemicals Limited → partners with → Neogen Morita New Materials Limited.

    Q3 FY26 · Closed / completed · Positive · Counterparty named; listed-company identity not verified.

    1. Proposed
    2. Announced
    3. Active
    4. Completed / ended

    To produce and sell LiPF6 salt globally, integrating 30 years of proven Japanese technology and accelerating international customer approvals.

    Disclosed value: USD 20 million

    “We have successfully concluded a joint venture with Japan's Morita Investment Limited to produce and sell LiPF6 salt globally. Neogen will hold an 80% majority stake in the new entity - Neogen Morita New Materials Limited - supported by a $ 20 million investment from our partner for the rest of the stake.”

    Exact commercial direction is not specified; disclosed as a partnership or collaboration.

    Evidence drawer

    Evidence type: Transcript excerpt

    “We have successfully concluded a joint venture with Japan's Morita Investment Limited to produce and sell LiPF6 salt globally. Neogen will hold an 80% majority stake in the new entity - Neogen Morita New Materials Limited - supported by a $ 20 million investment from our partner for the rest of the stake.”

    Source company: Neogen Chemicals Limited · Counterparty: Neogen Morita New Materials Limited · Call date: 2026-02-12 · Period: Q3 FY26 · Review status: Structured call extraction

Similar pressures reported by peers

Tailwind coverage is not available yet.

Similar commentary provides sector context; it does not establish a business relationship with Neogen Chemicals Limited. Each comparison matches a headwind disclosed by Neogen Chemicals Limited in the same calendar reporting quarter.

  • Middle East geopolitical conflicts and feedstock inflation caused supply chain friction, but…

    Topic: Supply chain disruption · Logistics supply chain · Q2 FY27

    Neogen Chemicals Limited reported: Middle East geopolitical conflicts and feedstock inflation caused supply chain friction, but operations were swiftly pivoted toward high-demand applications.

    Reporting period ended 2026-09-30

    10 other companies · Logistics supply chain

    Solar Industries India Limited (SOLARINDS) reported (period ended 2026-09-30): Fluctuating raw material and commodity prices alongside supply chain disruptions prevented management from publishing formal upward guidance revisions.

    Pidilite Industries Limited (PIDILITIND) reported (period ended 2026-09-30): Exports into or through West Asia are underperforming, and moving goods remains a challenge.

    Navin Fluorine International Limited (NAVINFLUOR) reported (period ended 2026-09-30): Global supply chains remain volatile, requiring continuous organizational agility and efficiency initiatives to protect operating margins.

    PRASOLCHEM (PRASOLCHEM) reported (period ended 2026-09-30): The company is a net importer; it is mitigating with ₹25 crores of storage tanks and expects more domestic/east-coast acetone supply and barge logistics.

    Evidence drawer

    Evidence type: Summary paraphrase

    Middle East geopolitical conflicts and feedstock inflation caused supply chain friction, but operations were swiftly pivoted toward high-demand applications.

    Source company: Neogen Chemicals Limited · Reporting period ended 2026-09-30 · Calendar quarter: Q2 FY27 · Distinct companies matched: 10

    Similar commentary provides sector context; it does not establish a business relationship.

Mentions over time

First observed: Q4 2025 · Latest observed: Q3 2026

Recorded disclosures by calendar reporting quarter
PeriodOther callsOwn calls
Q3 202601
Q1 202601
Q4 202501

Counts reflect the calls covered here. No mention in a period does not establish that a relationship ended.

From available earnings-call summaries. Disclosures are management statements, not independently verified transactions.

Live Summary

NEOGEN ₹2,665.2 +1.40%
Guidance Verdict (33 tracked) 2 kept · 23 open· 8 missed
AI Call Brief · Q2 FY27

Neogen Chemicals Limited Q2 FY27

Overview

Symbol
NSE:NEOGEN
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Neogen Chemicals Limited does

Based on the company's own presentations, annual report and earnings calls.

Neogen Chemicals is a specialty chemicals manufacturer built around Bromine and Lithium chemistry, making Organic Chemicals (bromine compounds, organolithium/N-Butyl Lithium reagents, advanced brominated intermediates, and custom synthesis/contract manufacturing) and Inorganic Chemicals (specialty lithium-based compounds) sold to pharmaceutical, agrochemical, semiconductor, electronics, flavours & fragrances and construction-chemical customers. It runs four manufacturing plants plus two in-house R&D centres, and exports to multiple countries. Through wholly-owned subsidiary Neogen Ionics it is forward-integrating into lithium-ion battery materials (electrolytes and lithium electrolyte salts), building a dedicated greenfield facility at Pakhajan, Dahej PCPIR alongside its existing Dahej SEZ battery-chemicals plant.

Segments

  • Organic Chemicals
  • Inorganic Chemicals
  • Battery Chemicals (Neogen Ionics)
Manufacturing sites
4 (Mahape–Navi Mumbai; Karakhadi–Vadodara, Gujarat; Dahej SEZ, Gujarat; Patancheru–Hyderabad, Telangana)
R&D facilities
2
Employees
905 (of which ~14% in R&D)
Products developed by in-house R&D
258
Countries exported to
33
New greenfield battery-materials site under construction
Pakhajan, Dahej PCPIR — 264,285 sq. m (~65 acres)
Founded 1989Headquarters Thane, Maharashtra, IndiaEmployees 905 (Q4 FY26 (Mar 2026)) Company website

How the price took the results

Moved an average of ±3.0% across the last 5 priced result releases

Close before → close after
QuarterReleaseRevenue (₹ Cr) Net profit (₹ Cr)Rev YoYBefore → AfterReaction
Q2 FY272 Nov 2639 21+457.1%₹2,171.4 → ₹2,095.4−3.5%
Q1 FY2727 Jul 2637 19+640.0%₹2,062.8 → ₹2,064.1+0.1%
Q4 FY2618 May 2622 15—₹1,664.8 → ₹1,691.1+1.6%
Q3 FY2612 Feb 268 9−63.6%₹1,302.2 → ₹1,301.2−0.1%
Q2 FY2610 Nov 257 9—₹1,452.3 → ₹1,308.5−9.9%

The move from the last close before each results date to the first close on or after it — the market's first read on the quarter alongside what was filed.

Your own record

Start an Inve Case for Neogen Chemicals Limited

Free account: one company. Everything above stays public.

Write why you follow Neogen Chemicals Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

PEER COMPARISON
Median ₹7,897 Cr Mkt Cap
₹0 Cr₹5,000 Cr₹10,000 Cr₹15,000 CrNeogen Chemicals Limited (NEOGEN): ₹7,897 Cr₹7,897 CrNEOGENJubilant Ingrevia Limited (JUBLINGREA): ₹9,130 Cr₹9,130 CrJUBLINGREAMadhya Bharat Agro Products Limited (MBAPL): ₹9,071 Cr₹9,071 CrMBAPLSudarshan Chemical Industries Limited (SUDARSCHEM): ₹8,390 Cr₹8,390 CrSUDARSCHEMAlkyl Amines Chemicals Limited (ALKYLAMINE): ₹8,274 Cr₹8,274 CrALKYLAMINEGalaxy Surfactants Limited (GALAXYSURF): ₹7,790 Cr₹7,790 CrGALAXYSURFSWAN CORP LIMITED (SWANCORP): ₹7,618 Cr₹7,618 CrSWANCORPKrishana Phoschem Limited (KRISHANA): ₹7,580 Cr₹7,580 CrKRISHANAClean Science and Technology Limited (CLEAN): ₹7,214 Cr₹7,214 CrCLEAN

All Chemicals companies → · Chemicals earnings growth →

Quick Answers

Frequently asked questions on Neogen Chemicals Limited

Compiled directly from NEOGEN's filed financial statements, earnings call transcripts, and ownership disclosures.

How did Neogen Chemicals Limited (NEOGEN) perform in its latest reported quarter (Sept 2026)?

For the quarter ended Sept 2026, Neogen Chemicals Limited reported revenue of ₹39 Cr, net profit of ₹21 Cr, an operating margin of 19.0%. Diluted earnings per share stood at ₹7.04.

How is Neogen Chemicals Limited (NEOGEN) valued today, and what growth does the stock price imply?

Neogen Chemicals Limited (NEOGEN) trades at ₹2,665.2, with a market capitalization of ₹7.9k Cr.

Who owns Neogen Chemicals Limited (NEOGEN) — promoters, FIIs, DIIs, and mutual funds?

As of Sept 2026, Promoters hold 48.3%, FIIs hold 4.1%, DIIs hold 23.5%, Public shareholders hold 24.1%.

Learn to analyse Neogen Chemicals Limited

Guides on how to read this kind of business and the numbers that matter.